Table S1 from Glucocorticoids Unleash Immune-dependent Melanoma Control through Inhibition of the GARP/TGFβ Axis

2026 Open access

Read full text
Authors: Charles H. Earnshaw, Poppy Dunn, Shih‐Chieh Chiang, Agrin Moeini, Maria A. Koufaki, Eduardo Bonavita, Massimo Russo, Laëtitia Nebot-Bral, Kimberley Hockenhull, Erin Richardson, Anna Pidoux, Charlotte R. Bell
+12 more Alexander R. Baker, Richard Reeves, Robert Sellers, Sudhakar Sahoo, Victoria Elisabeth Richardsdot Fife, Matthew G. Roberts, Theophile Bigirumurame, Caroline Dive, Julia Newton‐Bishop, Jérémie Nsengimana, Christopher E.M. Griffiths, Santiago Zelenay
DOI: 10.1158/2159-8290.31276857
Cited by: 0

Abstract

Overlapping DEGs following GC-treatment in vivo and in vitro, leading to development of GC-stimulated gene signature (related to Fig. 4).

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers TGF-β signaling in diseases T-cell and B-cell Immunology

Publication details

Publication date
6 February 2026